PD10-11 PROSTATE-SPECIFIC ANTIGEN (PSA) OUTCOMES IN PATIENTS (PTS) WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) TREATED WITH APALUTAMIDE (APA): RESULTS FROM PHASE 3 SPARTAN STUDY
2019 ◽
Vol 201
(Supplement 4)
◽
2016 ◽
Vol 15
(3)
◽
pp. e775-e775a
◽
2012 ◽
Vol 11
(1)
◽
pp. e918-e918a
◽
2021 ◽